|
1
|
Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff
M, Mills GB and Kornblau SM: Reverse phase protein array:
validation of a novel proteomic technology and utility for analysis
of primary leukemia specimens and hematopoietic stem cells. Mol
Cancer Ther. 5:2512–2521. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gujral TS, Karp RL, Finski A, Chan M,
Schwartz PE, MacBeath G and Sorger P: Profiling phospho-signaling
networks in breast cancer using reverse-phase protein arrays.
Oncogene. 32:3470–3476. 2013. View Article : Google Scholar :
|
|
3
|
Nishizuka S, Charboneau L, Young L, Major
S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina
V, et al: Proteomic profiling of the NCI-60 cancer cell lines using
new high-density reverse-phase lysate microarrays. Proc Natl Acad
Sci USA. 100:14229–14234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boyd ZS, Wu QJ, O'Brien C, Spoerke J,
Savage H, Fielder PJ, Amler L, Yan Y and Lackner MR: Proteomic
analysis of breast cancer molecular subtypes and biomarkers of
response to targeted kinase inhibitors using reverse-phase protein
microarrays. Mol Cancer Ther. 7:3695–3706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He L, Li X, Luo HS, Rong H and Cai J:
Possible mechanism for the regulation of glucose on proliferation,
inhibition and apoptosis of colon cancer cells induced by sodium
butyrate. World J Gastroenterol. 13:4015–4018. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Elf SE and Chen J: Targeting glucose
metabolism in patients with cancer. Cancer. 120:774–780. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee AS: Glucose-regulated proteins in
cancer: molecular mechanisms and therapeutic potential. Nat Rev
Cancer. 14:263–276. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park ES, Rabinovsky R, Carey M, Hennessy
BT, Agarwal R, Liu W, Ju Z, Deng W, Lu Y, Woo HG, et al:
Integrative analysis of proteomic signatures, mutations, and drug
responsiveness in the NCI 60 cancer cell line set. Mol Cancer Ther.
9:257–267. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu H, Baroukh C, Dannenfelser R, Chen EY,
Tan CM, Kou Y, Kim YE, Lemischka IR and Ma'ayan A: ESCAPE: database
for integrating high-content published data collected from human
and mouse embryonic stem cells. Database (Oxford).
2013.bat0452013.
|
|
10
|
Kim N, Park H, He N, Lee HY and Yoon S:
QCanvas: an advanced tool for data clustering and visualization of
genomics data. Genomics Inform. 10:263–265. 2012. View Article : Google Scholar
|
|
11
|
Saltiel AR and Kahn CR: Insulin signalling
and the regulation of glucose and lipid metabolism. Nature.
414:799–806. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Priebe A, Tan L, Wahl H, Kueck A, He G,
Kwok R, Opipari A and Liu JR: Glucose deprivation activates AMPK
and induces cell death through modulation of Akt in ovarian cancer
cells. Gynecol Oncol. 122:389–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Coloff JL, Mason EF, Altman BJ, Gerriets
VA, Liu T, Nichols AN, Zhao Y, Wofford JA, Jacobs SR, Ilkayeva O,
et al: Akt requires glucose metabolism to suppress puma expression
and prevent apoptosis of leukemic T cells. J Biol Chem.
286:5921–5933. 2011. View Article : Google Scholar :
|
|
14
|
Gao M, Liang J, Lu Y, Guo H, German P, Bai
S, Jonasch E, Yang X, Mills GB and Ding Z: Site-specific activation
of AKT protects cells from death induced by glucose deprivation.
Oncogene. 33:745–755. 2014. View Article : Google Scholar
|
|
15
|
Taubes G: Cancer research. Ravenous for
glucose. Science. 335:312012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adekola K, Rosen ST and Shanmugam M:
Glucose transporters in cancer metabolism. Curr Opin Oncol.
24:650–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neary CL and Pastorino JG: Akt inhibition
promotes hexokinase 2 redistribution and glucose uptake in cancer
cells. J Cell Physiol. 228:1943–1948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim N, He N, Kim C, Zhang F, Lu Y, Yu Q,
Stemke-Hale K, Greshock J, Wooster R, Yoon S, et al: Systematic
analysis of genotype-specific drug responses in cancer. Int J
Cancer. 131:2456–2464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He N, Kim N, Song M, Park C, Kim S, Park
EY, Yim HY, Kim K, Park JH, Kim KI, et al: Integrated analysis of
transcriptomes of cancer cell lines and patient samples reveals
STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D. Mol
Cancer Ther. 13:2463–2473. 2014. View Article : Google Scholar : PubMed/NCBI
|
